Apollomics Inc. — Form SCHEDULE 13D/A
Filed August 17, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
This is an amended Schedule 13D/A filing by Chen Hung-Wen regarding beneficial ownership in Apollomics Inc. (CIK 0001944885), a pharmaceutical company. The filing was submitted on August 17, 2026, but the document text provided does not specify the actual ownership stake, dollar amounts, share counts, percentage changes, or what substantive amendments were made to the original disclosure.
Why this rating
Amendment to ownership disclosure; no substantive transaction or material change disclosed in provided text. Routine SEC compliance filing.
See more from August 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.